BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
7 hedge funds and large institutions have $4.26M invested in BriaCell Therapeutics Corp Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
60% more capital invested
Capital invested by funds: $2.67M → $4.26M (+$1.59M)
0.7% more ownership
Funds ownership: 9.04% → 9.73% (+0.7%)
0% more funds holding
Funds holding: 7 → 7 (0)
81% less call options, than puts
Call options by funds: $619K | Put options by funds: $3.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$236K |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$93.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $1.51M | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $1.08M | – | – | – |
|
|
PFM
3
Privium Fund Management
Amsterdam,
Netherlands
| $710K | +$236K | +78,837 | +40% |
|
|
KJHP
4
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $610K | +$93.9K | +31,440 | +17% |
|
|
RAM
5
Redmond Asset Management
Henrico,
Virginia
| $215K | – | – | – |
|
|
ZCA
6
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $129K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $8K | -$6.39K | -2,140 | -42% |
|
BCTXW Hedge Fund Activity: Q3 2022 in Review
7 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q3 2022, worth a combined $4.26M — up 60% from $2.67M a quarter earlier.
Fund positioning in BCTXW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Privium Fund Management, adding an estimated $236K. The largest seller was UBS Group, cutting an estimated $6.39K.
- 7 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $4.26M of BriaCell Therapeutics Corp Warrant stock for Q3 2022, up 60% quarter-over-quarter.
- 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q3 2022 and 0 closed out.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q3 2022 was Privium Fund Management, an estimated $236K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q3 2022 was UBS Group, an estimated $6.39K sold.
Based on aggregated 13F filings for Q3 2022.